21.3 Clinical Informatics, CPOE Decision Support & Drug Shortage Management
Key Takeaways
- Pediatric computerized provider order entry must capture weight in kilograms only, refuse to calculate from a stale or pounds-entered weight, and drive dose-range checking from weight and body surface area, because the kilogram-only standard is the single highest-yield structural defense against the pediatric tenfold error.
- Published override rates for interruptive medication alerts commonly range from roughly 50% to over 90%, so decision support must be tiered, reserving hard stops and interruptive alerts for genuinely lethal scenarios and delivering the rest passively.
- Closed-loop medication management combines CPOE with decision support, barcode-assisted dispensing, smart pumps with dose error reduction software, barcode medication administration, and bidirectional pump-to-electronic-health-record auto-programming, which removes manual pump keypad entry.
- Drug shortages hit pediatrics disproportionately because affected products are often low-margin, low-volume, sterile injectables and the substitute frequently arrives at a different concentration, creating a tenfold error risk at the moment of substitution.
- The FDA Drug Shortages Database and the ASHP shortage resource are the two authoritative sources, and ASHP guidelines frame shortage response as detect, assess supply against projected use, identify therapeutic alternatives through P&T, restrict and prioritize, communicate, and document.
21.3 Clinical Informatics, CPOE Decision Support & Drug Shortage Management
Clinical Informatics and Emergency Preparedness and Drug Shortage Resources are both listed under Practice Management in the BPS Pediatric Pharmacy content outline. They belong together because both are system-level defenses: informatics prevents the error that weight-based dosing invites, and shortage management prevents the error that an unexpected substitution invites.
Why Pediatric Informatics Is a Different Problem
An adult order for "metoprolol 25 mg PO BID" is fully specified. A pediatric order for "metoprolol 1 mg/kg/day divided BID" is a computation whose correctness depends on a stored weight, a unit convention, a rounding rule, and a concentration. Every one of those is a failure point.
The Kilogram-Only Standard
The Institute for Safe Medication Practices and The Joint Commission both call for recording and displaying pediatric weight in kilograms only. Dual units are how a 30-pound toddler receives a dose calculated for 30 kilograms — a 2.2-fold overdose that passes every downstream check because the arithmetic was flawless.
A safe pediatric CPOE configuration:
- Accepts and displays kilograms only in every clinical screen, order, label, and flowsheet.
- Requires a documented weight before any weight-based order can be signed.
- Flags a stale weight — what counts as stale differs by population, with neonates requiring a current daily weight and general pediatrics tolerating a few days.
- Shows the calculation on the order: mg/kg/dose, the weight used, and the resulting milligram amount, so a verifier can reproduce it.
- Blocks free-text dose entry for high-alert medications.
Dose Range Checking
Dose range checking (DRC) compares a calculated dose against age- and weight-indexed minimum and maximum values, ideally checking four dimensions at once: per dose, per kilogram per dose, per day, and against the adult maximum. It is the electronic implementation of the cap rule.
DRC in pediatrics is harder than in adults because a single drug can have three legitimate dosing schemes at once — gentamicin dosed per kilogram in neonates by post-menstrual age, extended-interval in older children, and synergy dosing in endocarditis. A poorly tuned DRC ruleset that fires on all three trains clinicians to override, which is worse than no rule.
Alert Fatigue and Tiering
Published override rates for interruptive medication-related alerts commonly run from roughly 50% to well over 90%. An alert that is overridden nine times out of ten is not a safety control; it is a click.
TIERING CLINICAL DECISION SUPPORT
HARD STOP Cannot be overridden without pharmacy or
(rare) physician-leader authorization.
Reserve for lethal events: intrathecal vincristine,
concentrated potassium chloride on a nursing unit,
10-fold-above-maximum chemotherapy doses.
INTERRUPTIVE Modal alert requiring a documented reason to proceed.
(uncommon) Reserve for high-severity, high-specificity events:
true contraindicated interactions, allergy with a
documented anaphylaxis history.
PASSIVE In-line display, order-set default, or info button.
(most) Duplicate therapy, moderate interactions, reference
dosing, renal adjustment suggestions.
DESIGNED OUT Best of all: standardized concentrations, pre-built
order sets, default rounding, forcing functions.
No alert is needed for an error that cannot be made.
Governance matters as much as design. High-performing programs measure override rate by rule, retire or re-specify any rule whose override rate exceeds a governance threshold, and require a pharmacist on the decision-support committee.
Standardized Concentrations and the Pump Library
The ASHP Standardize 4 Safety initiative established national standard concentrations for pediatric and neonatal continuous infusions. From an informatics standpoint, standardization is what makes a drug library possible at all: a single tested library entry per clinical care area can only exist if every patient receives the same concentration. It also enables batch preparation, reducing both waste and turnaround time. The internal mechanics of the pump library — clinical care areas, soft versus hard limits, override auditing, and the abandonment of patient-specific concentration calculation — are covered in the smart infusion pump section of the medication safety chapter.
Closed-Loop Medication Management
ORDER CPOE + clinical decision support + dose range checking
|
VERIFY Pharmacist review with pediatric-specific rules
|
PREPARE Barcode-assisted sterile compounding; gravimetric or
image-capture verification of the compounded product
|
DISPENSE Barcoded, patient-specific, unit-of-use label
|
ADMINISTER Barcode medication administration (BCMA): right
patient, right drug, right dose, right route, right time
|
INFUSE Smart pump with dose error reduction software; ideally
AUTO-PROGRAMMED from the EHR order, so no one types a
rate into a keypad
|
MONITOR Documentation flows back to the record; pump
compliance and override reports drive library updates
Two informatics facts worth holding: auto-programming (bidirectional pump-EHR interoperability) removes manual keypad entry, which is the last remaining place a decimal point can be misplaced by hand; and smart pump compliance reporting — the proportion of infusions started from the drug library rather than in basic infusion mode — is the metric that tells you whether the safety software is actually being used.
Drug Shortage Management
Why Shortages Are Worse in Pediatrics
Shortage-prone products are disproportionately older, low-margin, low-volume sterile injectables from a small number of manufacturing lines — precisely the profile of many pediatric staples. The pediatric consequences compound:
- No alternative dosage form. An adult can take an oral substitute; a 900 g neonate on continuous infusion frequently cannot.
- Concentration substitution is a tenfold-error generator. When the familiar 1 mg/mL product is replaced by a 10 mg/mL import, every stored order, pump library entry, and nursing habit becomes wrong on the same day.
- Imported products obtained under FDA temporary importation carry foreign labeling, different concentrations and units, and no barcode that scans in the local system.
- Compounding burden shifts to the pharmacy, bringing USP <795> and <797> obligations, stability uncertainty, and beyond-use-date limits.
- Excipient substitution. The replacement product may contain benzyl alcohol, propylene glycol, or ethanol in amounts that are irrelevant in adults and toxic in neonates.
Authoritative Sources
- FDA Drug Shortages Database — the regulatory source of record, reporting current shortages, resolved shortages, and reason categories. Manufacturers are required to notify the FDA of anticipated interruptions.
- ASHP Drug Shortages Resource Center — maintained with the University of Utah Drug Information Service; typically more clinically actionable, with management suggestions and alternative-agent guidance.
- ASHP Guidelines on Managing Drug Product Shortages — the framework below.
- Professional bodies such as the Pediatric Pharmacy Association issue pediatric-specific shortage guidance.
The Response Framework
| Step | Action | Pediatric specifics |
|---|---|---|
| 1. Detect & verify | Confirm with the wholesaler and the FDA/ASHP listings; establish expected duration | Do not act on a single backorder message |
| 2. Assess | Quantify on-hand inventory against projected use by indication | Pull actual pediatric utilization, not adult-weighted estimates |
| 3. Identify alternatives | P&T or a designated shortage team selects therapeutic alternatives | Confirm the alternative has pediatric dosing, an age-appropriate form, and an acceptable excipient profile |
| 4. Restrict & prioritize | Reserve remaining supply for indications with no substitute | Neonates and patients with no enteral route usually rank first |
| 5. Operationalize | Update the formulary, order sets, CPOE dose rules, smart pump library, automated dispensing cabinets, and labels before the substitute reaches the floor | This is the step that prevents the concentration-change tenfold error |
| 6. Communicate | Notify prescribers, nursing, and families with the specific change, not a general shortage notice | Name the old and new concentrations explicitly |
| 7. Document & review | Record decisions, adverse outcomes, and resolution | Feeds the next shortage and any regulatory reporting |
[!WARNING] The most dangerous day of a shortage is the day the substitute arrives. Standard concentration changes, imported foreign-labeled products, and unfamiliar vial sizes converge while clinical urgency is highest. Build the pump library entry, update the order sets, and brief nursing before the product is released to patient care areas.
Emergency Preparedness
Disaster and mass-casualty planning fails children by default, because caches and protocols are built around adult unit doses.
- Strategic National Stockpile and CHEMPACK caches contain nerve-agent antidotes; pediatric autoinjector doses of atropine and pralidoxime must be identified in advance, and pediatric dosing guidance kept with the cache.
- Potassium iodide for radiologic events is dosed by age, and thyroid blockade is most valuable in children because of their much higher radiation-induced thyroid cancer risk.
- Pediatric surge planning must account for weight-based dosing at scale, availability of oral liquids, and the fact that children arriving unaccompanied may have no weight, no history, and no identifier.
- Maintain downtime procedures: a paper weight-based dosing reference and pre-calculated code-dose sheets for when CPOE, the pump library, and barcode scanning are all unavailable.
Practice Pearls & BCPPS Exam Traps
- Exam Trap 1: The correct answer to "how do we stop the pounds-to-kilograms error?" is a structural one — kilogram-only capture and display — not another alert.
- Exam Trap 2: More alerts is not the safety answer. An option proposing a new interruptive alert to solve a problem already generating high override rates is almost always wrong; tiering, standardization, or a forcing function is the better answer.
- Exam Trap 3: During a shortage, the first operational task once an alternative is chosen is to update the pump library, order sets, and dose rules before the product is dispensed — not to email a notice and hope.
- Board Rule: Any shortage substitution that changes a concentration requires an explicit, documented change bundle: CPOE dose rule, smart pump entry, automated dispensing cabinet configuration, label, and nursing communication. Changing one and not the others is how a tenfold error reaches a patient.
A pediatric safety committee reviews a near-miss in which a 22-month-old was nearly given a dose calculated from a weight of 26 rather than 11.8, after a caregiver reported the weight in pounds at a clinic visit. Which intervention most directly prevents recurrence?
A national shortage of the 1 mg/mL premixed morphine infusion forces a children's hospital to substitute a 5 mg/mL product for continuous infusions in the pediatric intensive care unit. Which action should the pharmacy take FIRST, before the substitute product is released to patient care areas?
An informatics pharmacist reviews clinical decision support performance and finds that a drug-drug interaction alert for concurrent ondansetron and other QT-prolonging agents fires 640 times per month and is overridden 94% of the time, with no documented adverse events attributable to the combination. Which action best reflects sound decision support governance?
You've completed this section
Continue exploring other exams